DANIELLE FORRY: Open Payments
NPI 1447899125 · WYOMISSING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 10 payments from 7 companies in 2025. Trend: 2023 $2,180 · 2024 $844 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Celltrion USA Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| GENZYME CORPORATION | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
Products named: ENTYVIO, DUPIXENT, VEGZELMA, MAVYRET, RINVOQ, XIFAXAN, SKYRIZI, VOQUEZNA.
Industry payments across PA — which companies pay providers there.
